BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34866200)

  • 1. Effect of pulsatility on shear-induced extensional behavior of Von Willebrand factor.
    Wang Y; Nguyen KT; Ismail E; Donoghue L; Giridharan GA; Sethu P; Cheng X
    Artif Organs; 2022 May; 46(5):887-898. PubMed ID: 34866200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of pulsatility with continuous-flow left ventricular assist devices and the significance of the arterial endothelium in von-Willebrand factor production and degradation.
    Giridharan GA; Berg IC; Ismail E; Nguyen KT; Hecking J; Kirklin JK; Cheng X; Sethu P
    Artif Organs; 2023 Apr; 47(4):640-648. PubMed ID: 36404709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.
    Vincent F; Rauch A; Loobuyck V; Robin E; Nix C; Vincentelli A; Smadja DM; Leprince P; Amour J; Lemesle G; Spillemaeker H; Debry N; Latremouille C; Jansen P; Capel A; Moussa M; Rousse N; Schurtz G; Delhaye C; Paris C; Jeanpierre E; Dupont A; Corseaux D; Rosa M; Sottejeau Y; Barth S; Mourran C; Gomane V; Coisne A; Richardson M; Caron C; Preda C; Ung A; Carpentier A; Hubert T; Denis C; Staels B; Lenting PJ; Van Belle E; Susen S
    J Am Coll Cardiol; 2018 May; 71(19):2106-2118. PubMed ID: 29747831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
    Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand Factor and Angiopoietin-2 are Sensitive Biomarkers of Pulsatility in Continuous-Flow Ventricular Assist Device Patients.
    Nguyen KT; Hecking J; Berg IC; Kannappan R; Donoghue L; Ismail E; Cheng X; Giridharan GA; Sethu P
    ASAIO J; 2023 Jun; 69(6):569-575. PubMed ID: 37000917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of shear stress on the size, structure, and function of human von Willebrand factor.
    Chan CH; Pieper IL; Fleming S; Friedmann Y; Foster G; Hawkins K; Thornton CA; Kanamarlapudi V
    Artif Organs; 2014 Sep; 38(9):741-50. PubMed ID: 25234758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a mathematical model for evaluating shear-induced damage of von Willebrand factor.
    Li Y; Xi Y; Wang H; Sun A; Wang L; Deng X; Chen Z; Fan Y
    Comput Biol Med; 2023 Sep; 164():107379. PubMed ID: 37597407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of flow-modulation approaches in ventricular assist devices using an in-vitro endothelial cell culture model.
    Haglund TA; Rajasekaran NS; Smood B; Giridharan GA; Hoopes CW; Holman WL; Mauchley DC; Prabhu SD; Pamboukian SV; Tallaj JA; Rajapreyar IN; Kirklin JK; Sethu P
    J Heart Lung Transplant; 2019 Apr; 38(4):456-465. PubMed ID: 30503074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.
    Lukito P; Wong A; Jing J; Arthur JF; Marasco SF; Murphy DA; Bergin PJ; Shaw JA; Collecutt M; Andrews RK; Gardiner EE; Davis AK
    J Thromb Haemost; 2016 Nov; 14(11):2253-2260. PubMed ID: 27601054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
    Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
    Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical model for assessing shear induced bleeding risk.
    Li Y; Wang H; Xi Y; Sun A; Wang L; Deng X; Chen Z; Fan Y
    Comput Methods Programs Biomed; 2023 Apr; 231():107390. PubMed ID: 36745955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shear Stress-Induced Total Blood Trauma in Multiple Species.
    Chan CHH; Pieper IL; Robinson CR; Friedmann Y; Kanamarlapudi V; Thornton CA
    Artif Organs; 2017 Oct; 41(10):934-947. PubMed ID: 28744884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.
    Crow S; Milano C; Joyce L; Chen D; Arepally G; Bowles D; Thomas W; Ortiz NV
    ASAIO J; 2010; 56(5):441-5. PubMed ID: 20613494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
    Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
    Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.